Manning & Napier Group's UTHR Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 7 shares of United Therapeutics Corporation (UTHR) worth $4,155, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Manning & Napier Group has initiated a new position in UTHR, representing a fresh investment thesis on this company.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's United Therapeutics Corporation (UTHR) Holding Value Over Time
Track share changes against reported price movement
Quarterly United Therapeutics Corporation (UTHR) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +7 | New Buy | 7 | $544.86 |
Manning & Napier Group's United Therapeutics Corporation Investment FAQs
Manning & Napier Group first purchased United Therapeutics Corporation (UTHR) in Q2 2026, acquiring 7 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held United Therapeutics Corporation (UTHR) for 2 quarters since Q2 2026.
Manning & Napier Group's largest addition to United Therapeutics Corporation (UTHR) was in Q2 2026, adding 7 shares worth $3,814.
According to the latest 13F filing for Q3 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 7 shares of United Therapeutics Corporation (UTHR), valued at approximately $4,155.
As of the Q3 2026 filing, United Therapeutics Corporation (UTHR) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in United Therapeutics Corporation (UTHR) was 7 shares, as reported at the end of Q2 2026.